Askel Healthcare is on a mission to provide a truly regenerative treatment for cartilage lesions. The COPLA® Scaffold was developed based on a decade of scientific research and is now offered to veterinary surgeons to provide healing not just treatment for dog and horse cartilage lesions. Founded by experienced scientists from the fields of tissue engineering, material science, cell biology, and orthopedics the research team had one goal: to provide a solution for the unmet medical need of cartilage regeneration. The technology of the COPLA® Scaffold is well suited to treat many species including human beings. Making our solutions available for human medicine is a long-term project that we want to achieve in the most ethical way. One of the goals of Askel Healthcare is to explore the possibility to expedite human market access by utilizing the clinical results from veterinary use, and thus create a true interspecies partnership.